메뉴 건너뛰기




Volumn 2, Issue 4, 2001, Pages 301-311

Monoclonal antibodies: A new era in the treatment of non-Hodgkin's lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ALEMTUZUMAB; ALPHA INTERFERON; ALPHA2A INTERFERON; ANTIIDIOTYPIC ANTIBODY; APOLIZUMAB; CD19 ANTIGEN; CD22 ANTIGEN; CD52 ANTIGEN; CHELATING AGENT; CHIMERIC ANTIBODY; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPRATUZUMAB; GEMTUZUMAB OZOGAMICIN; HU1D10 ANTIBODY; IBRITUMOMAB TIUXETAN; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY; OKB7; OKT 3; ORTHOCLONE; PENTETIC ACID DERIVATIVE; PREDNISONE; RECOMBINANT INTERLEUKIN 2; RITUXIMAB; TOSITUMOMAB I 131; TRASTUZUMAB; UNCLASSIFIED DRUG; VINCRISTINE; YTTRIUM;

EID: 0035211785     PISSN: 13892010     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389201013378563     Document Type: Article
Times cited : (22)

References (79)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.